I agree although I be,lwhat took them 3 weeks was reviewing the safety data more so than the efficacy part. Vaccines were under such a spotlight by the speed In Which they were developed , the FDA really wanted to ensure how safe these were. They still really don’t know how long the efficacy will last because they haven’t finish their trials yet.
With Cytodyn, efficacy isn’t an issue. After being in clinicals for years for HIV patients plus the fact it appears the FDA has pigeon-holed Leronlimab as primarily a drug for the very sick and dying , I believe EUA is at least at the speed of the vaccine approvals.